EZH2 Epigenetic Modification Drives Lung Cancer Growth via miR-152 Repression
A new study identifies the EZH2/miR-152/HK2 signaling axis as a critical regulator of lung cancer progression and glycolytic metabolism.
A new study identifies the EZH2/miR-152/HK2 signaling axis as a critical regulator of lung cancer progression and glycolytic metabolism.
A study reveals that loss of the enzyme HAT1 drives glioblastoma growth and increases membrane fluidity through an ALDH2-mediated lipid ...
A study combining transcriptomic datasets, cell line assays, and in vivo xenograft models found that lncRNA AC079922.2 promotes gastric cancer ...
Researchers found that DSN1 promotes cell proliferation and tumor growth in triple-negative and basal-like breast cancer models by activating the ...
Researchers found that bile acid stress drives the transcription factor TFAP2A to stabilize Golgi protein GOLIM4 in the cytoplasm, alleviating ...
A systematic review of 34 preclinical studies indicates that escin and its nanoformulations significantly inhibit cancer cell growth and reduce ...
A study across independent clinical cohorts and preclinical models identifies long noncoding RNA SNHG4 as a candidate regulator of colorectal ...
A new study reveals that PIK3CA promotes liver tumor growth by helping tumors evade phagocyte-mediated immune responses, suggesting that PIK3CA ...
Researchers identified a CTCF-FADS1 regulatory axis that controls energy metabolism and tumor growth in hepatocellular carcinoma cells.
Researchers found that the kinase DAPK1 stabilizes Lipin1 to boost fatty acid oxidation, raising lipid peroxidation and making colorectal cancer ...
A new study shows the transcription factors SIX1 and TEAD1 synergistically promote colorectal tumor growth by directly co-regulating the CTGF ...
A mouse study in The Journal of Immunology reports that hyperglycemia reprograms T cells through an IGF1-IGF1R signaling pathway to ...
A new study reports that blocking SMYD3 limits uveal melanoma cell proliferation, migration, invasion and tumor growth by regulating the ...
Preclinical experiments found that erianin reduced prostate cancer cell activity and mouse tumor growth while lowering phosphorylation of the STAT3 ...
A mouse study found that directly reducing lung cancer cells’ dependence on phospholipase D1 significantly slowed tumor growth, but clinical ...
A preclinical study links elevated NDUFS1, a mitochondrial complex I subunit, to breast cancer progression through increased respiration and PROX1–c-Myc ...
A CD276-targeted antibody-drug conjugate combined with mitochondrial-disrupting gene therapy outperformed either treatment alone in two preclinical models of metastatic triple-negative ...
A new study shows that cancer cells selectively erode gene-rich regions of the Y chromosome, disrupting regulatory pathways and opening ...
New research in The FEBS Journal links mitochondrial DNA copy number in cancer cells to mutational load, tumor growth gene ...
A retrospective study of 75 patients found that most medullary thyroid microcarcinomas grew during delayed surgery, with larger tumors linked ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.